131I-L19SIP

L19SIP radiopharmaceutical (radioimmunotherapy) · Philogen S.p.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 131I-L19SIP, covering 2011-11-22 to 2014-02-25. Get the full timeline:

Most recent: Clinical Trial Update: 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors [Phase 2]

See pricing